Pseudoautosomal Linkage of Hodgkin Disease

Hodgkin\'s Disease

SUMMARY  Hodgkin's disease has been known to medical practitioners for more than three centuries. The clinical and pathologic description of the disease published by Thomas. Hodgkin first in 183 2 when reported seven cases th-at he considered a new clinical entity.  The incident, clinical feature, histologic, procedure of evaluation and staging of Hodgkin's disease are presented briefly. Part...

Epidemiology and Epidemics of Hodgkin Disease

This article has no abstract

expressed in Hodgkin disease

1. Lu W, Andrieu JM. HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism. Blood. 2000;96:250-258. 2. Kaufmann D, Pantaleo G, Sudre P, Telenti A. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART): Swiss HIV cohort study. Lancet. 1998;351:723-724. 3. L...

Skeletal manifestations of leukemia, Hodgkin disease, and non-Hodgkin lymphoma.

The Eutherian Pseudoautosomal Region.

The pseudoautosomal region (PAR) is a unique segment of sequence homology between differentiated sex chromosomes where recombination occurs during meiosis. Molecular and functional properties of the PAR are distinctive from the autosomes and the remaining regions of the sex chromosomes. These include a higher rate of recombination than genome average, bias towards GC-substitutions and increased...